Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025)
Beta Bionics' (BBNX) quarterly Asset Writedowns and Impairment came in at $16000.0 in Q4 2025, down 38.46% year-over-year from $26000.0 in Q4 2024, and down 33.33% quarter-over-quarter from $24000.0 in Q3 2025.
Powered by 
Analysis
Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Beta Bionics has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $16000.0 for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment fell 38.46% year-over-year to $16000.0; the TTM figure through Dec 2025 stood at $40000.0 (down 42.86% YoY), while the FY2025 annual figure was $40000.0, down 42.86% from the prior year.
- Asset Writedowns and Impairment came in at $16000.0 for Q4 2025 at Beta Bionics, down from $24000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $27000.0 in Q2 2024 to a low of $16000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 17,000.00 |